ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

KALA KALA BIO Inc

6.30
0.12 (1.94%)
26 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
KALA BIO Inc KALA NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.12 1.94% 6.30 23:00:14
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
6.32 6.24 6.5399 6.30 6.18
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
29/3/202407:00GLOBEKALA BIO Reports Fourth Quarter and Full Year 2023 Financial..
04/3/202406:30EDGAR2Form 8-K - Current report
26/2/202407:00GLOBEKALA BIO to Present at TD Cowen 44th Annual Healthcare..
14/2/202412:09EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/2/202407:00GLOBEKALA BIO to Present at Oppenheimer 34th Annual Healthcare..
19/1/202415:01GLOBEKALA BIO Reports Inducement Grants Under Nasdaq Listing Rule..
05/1/202415:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202415:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202415:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/1/202415:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/12/202307:22EDGAR2Form 8-K - Current report
13/11/202307:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202307:05EDGAR2Form 8-K - Current report
13/11/202307:00GLOBEKALA BIO Reports Third Quarter 2023 Financial Results and..
18/10/202315:04EDGAR2Form SC 13D/A - General statement of acquisition of..
20/9/202315:01GLOBEKALA BIO Reports Inducement Grants Under Nasdaq Listing Rule..
05/9/202307:00GLOBEKALA BIO to Present at H.C. Wainwright 25th Annual Global..
04/8/202307:00GLOBEKALA BIO Reports Second Quarter 2023 Financial Results and..
02/8/202315:01EDGAR2Form 8-K - Current report
02/8/202315:01GLOBEKALA BIO to Participate in Upcoming Investor Conferences in..
02/8/202307:00GLOBEKala Pharmaceuticals Announces Name Change to KALA BIO
19/7/202315:01GLOBEKala Pharmaceuticals Reports Inducement Grants Under Nasdaq..
23/6/202315:01GLOBEKala Pharmaceuticals Reports Inducement Grants Under Nasdaq..
02/6/202307:00GLOBEKala Pharmaceuticals to Present at the Jefferies Healthcare..
09/5/202307:00GLOBEKala Pharmaceuticals Reports First Quarter 2023 Financial..

Su Consulta Reciente

Delayed Upgrade Clock